Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States

By sjmartinez • January 7, 2023

Nicholas SB, Alicic RZ, Shen J. Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States. Kidney Med. 2022 Dec 15;5(1):100590. doi: 10.1016/j.xkme.2022.100590. PMID: 36605084; PMCID: PMC9807823.

Tags: Harbor UCLA, Nephrology, Publications

Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia

Jang J, Nold T, Marshalek JP, Matthiesen J, Tomassetti S. Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia. J Oncol[...]

CT Emphysema and Deep Learning-derived Vertebral Bone Loss in Individuals without COPD: Findings from MESA

Ghotbi E, Hathaway QA, Jannatdoust P, Hadidchi R, Bancks MP, Bluemke DA, Budoff M, Post W, Hoffman EA, Smith BM, Lima JAC, Barr RG, Demehri[...]

Predictors of bleeding-related in-hospital complications after coronary angiography and percutaneous coronary intervention: A single-center retrospective cohort study in Iran

Andishmand A, Soltani MH, Mohammadi H, Namayandeh SM, Peigan P, Budoff M, Azimizadeh M, Andishmand M, Andishmand M. Predictors of bleeding-related in-hospital complications after coronary[...]